Advances in posttransplanl immunosuppression have to the present not been able to
prevent the development of graft-versus-host disease (GVHD) in patients given related or …

Background: Extracorporeal photopheresis (ECP) is a second-line therapy for steroid-
refractory chronic graft-versus-host disease (cGVHD). Objective: We describe the long-term …

Chronic graft-versus-host disease (GVHD) is almost always associated with skin diseases
appearing either as lichenoid GVHD, sclerodermatous GVHD (sGVHD) or as eosinophilic …

Graft-versus-host disease is a frequent complication of allogenic bone marrow
transplantation. Approximately 10% of patients suffering from chronic graft-versus-host …

Chronic graft-versus host disease (cGVHD) occurs in 30% to 70% of patients undergoing
allogeneic hematopoietic cell transplantation (HCT). Cutaneous cGVHD affects 75% of …

Over 15,000 patients per year are treated with allogeneic stem cell transplantation as an
intervention for cancer, primary immunodeficiency, and other serious heritable and acquired …

Graft‐versus‐host disease (GVHD) is one of the major complications after hematopoietic
stem cell transplantation and is responsible for post‐therapeutic morbidity, mortality, and …

Psoralen plus ultraviolet A irradiation (PUVA) has immunomodulatory effects and is used to
treat a variety of immune-mediated dermatologic diseases. We administered PUVA to 103 …

We enrolled 25 patients with extensive, steroid-refractory chronic graft-versus-host disease
(cGVHD) in a prospective trial evaluating the efficacy of extracorporeal photophoresis (ECP) …

StR. In cbronic graft-versus-bost (GVH) disease cytotoxic and suppressor T lymphocytes
probably play the decisive pathogenetic role.'Conventional immunosuppressive therapy is …